# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-25T13:40:15.711627

---

**Idea Fidelity**

The paper diverges materially from the original idea manifest. The manifest promised to exploit the UK calorie labeling threshold as a firm-size regression discontinuity, drawing on menu-level calorie data, web-scraped delivery-platform listings, and consumer surveys to study both menu composition and demand. It also highlighted a cross-border (England vs. Scotland/Wales) difference-in-differences design around the April 2022 mandate. Instead, the submitted paper focuses exclusively on aggregate enterprise counts drawn from the ONS Business Counts dataset and implements a triple-difference at the country × industry × time level. There is no use of the promised menu-level data, no direct study of consumer demand, and no RDD around the 250-employee cutoff. Consequently, key elements of the identification strategy and empirical approach articulated in the manifest are missing from the paper.

---

**Summary**

The paper examines whether England’s 2022 calorie labeling regulation—applicable to food-sector enterprises with 250+ employees—distorted the size distribution of food businesses. Using yearly enterprise counts from ONS Business Counts for England, Scotland, and Wales across treated and control sectors, the author employs a triple-difference specification with extensive fixed effects to compare pre- and post-2022 trends. The central finding is a null effect: no detectable change in total enterprise counts, the share of large firms, or the density around the 250-employee threshold following the mandate.

---

**Essential Points**

1. **Credibility of Control Group and Parallel Trends**  
   The triple-difference relies on the assumption that control sectors (retail, accommodation, IT, legal) in England and all sectors in Scotland/Wales adequately capture the counterfactual evolution of English food services absent the policy. Yet these industries differ substantially in exposure to COVID, input costs, and regulatory changes during the 2010–24 period. While the paper presents event-study coefficients for the treated cell, it does not show parallel trends for the aggregated control cell or rule out pre-existing diverging patterns between treated and control industries within England, especially in light of pandemic disruptions. Without this, the identifying assumption remains unverified.

2. **Annual Aggregation, Limited Post-period, and Timing of Treatment**  
   The outcome data are yearly March snapshots, with only two post-treatment observations (March 2023 and 2024). Given the regulation took effect in April 2022, the March 2023 data capture only one year of exposure. Firms may take longer to reorganize, and annual snapshots can mask timing dynamics (e.g., late 2022 changes). This temporal coarseness weakens the ability to link the estimated effects to the policy and raises concerns about statistical power and the meaningfulness of the null finding.

3. **Coarse Measurement around the Threshold and Power Considerations**  
   The ONS size bands are very wide, with the threshold spanning entire employment brackets (100–249 vs. 250–499). This limits the paper’s ability to identify bunching or avoidance behavior precisely at the cutoff. Additionally, the enterprise counts are rounded to the nearest five, and large firms constitute only some hundreds of the treated units, making inference noisy. The Minimum Detectable Effect (MDE) calculation suggests the study can only rule out very large distortions (≈13%). Yet the policy relevance hinges on smaller behavioral responses. Greater granularity—either within the employment distribution or at the firm level—is needed to credibly rule out economically meaningful adjustments to the threshold.

---

**Suggestions**

1. **Bolster the Parallel Trends Evidence**  
   To support the triple-difference assumption, present visual or statistical tests comparing the treated and control cells over pre-treatment years, ideally separately for each country and industry. For example, plot the trajectories of log enterprise counts for English food services against each control sector, and show that the triple-difference residual is flat before 2022. Alternatively, compute placebo triple-difference estimates using earlier “pseudo-treatment” dates and demonstrate that these are null. If control sectors experienced shocks (e.g., pandemic-related restrictions) that the treated sector did not, consider excluding those periods or sectors and reassess whether the null result holds.

2. **Enrich the Temporal Dimension**  
   Annual data severely limit both precision and the ability to trace adjustment dynamics. If feasible, exploit more frequent snapshots (quarterly or monthly) from the IDBR or Companies House filings to increase the number of post-treatment observations and better align the timing with the April 2022 implementation. Such data would also allow the use of event-study plots with more granular leads and lags, making it easier to detect or reject anticipatory behavior or delayed responses. This would also strengthen the power analysis: with more time-series variation, the MDE would shrink, and the null estimate would be more informative.

3. **Pursue More Granular or Alternative Outcomes**  
   The current outcomes—total enterprise counts, large share, and coarsely defined ratios—are too aggregated to capture fine-grained behavioral adjustments around the threshold. Consider using micro-level employment data (e.g., firm-level annual employment from Companies House or the FAME database) to directly observe how firms near the 250-employee mark respond. Alternatively, a regression discontinuity design exploiting the continuum of reported employment (if available) would align tightly with the manifest’s original idea and allow for more precise estimates of bunching or avoidance. Even within the ONS data, exploring counts for narrower overlapping bands (if possible) or examining stocks of establishments (rather than enterprises) might provide more sensitivity.

4. **Connect to the Mandate’s Mechanism and Compliance Costs**  
   The policy implication hinges on the assertion that compliance costs are too small to distort firm structure. Strengthen this claim by incorporating direct evidence on compliance behavior: e.g., the number of firms explicitly preparing nutritional analyses, the speed of label adoption among chains of different sizes, or qualitative survey data on the burden. If firms voluntarily adopted labeling or if the regulation’s enforcement was gradual, the absence of firm-size responses is less informative. Even aggregated proxies—such as announcements from chains on compliance investments or differential use of third-party labeling services—could contextualize the null.

5. **Refine the Power and Effect-size Discussion**  
   The MDE reported is sizeable and could be interpreted as the study being underpowered to detect economically relevant effects. Augment this section with simulation-based power analyses across alternative specifications (e.g., using different subsets of control sectors or excluding COVID years) to demonstrate robustness. Additionally, provide standardized effect sizes or elasticity interpretations to give readers a better sense of the magnitude of potential responses that are ruled out. If finer-grained data are unavailable, explicitly acknowledge that the study can only rule out “large” distortions and clarify what smaller but policy-relevant distortions remain untested.

6. **Clarify the Role of Scotland and Wales**  
   The paper treats Scotland and Wales as untreated controls, but their food sectors may have experienced distinct regulatory or economic shocks unrelated to England’s policy. Expound on why these regions provide valid counterfactuals (e.g., similarity in consumer tastes, shared macro shocks) and explore sensitivity by excluding one region at a time. If Northern Ireland data are available, including it—either as another control or to test robustness—could increase confidence in the geographic dimension of the identification strategy.

7. **Align More Closely with the Prior Manifest or Situate the Deviation**  
   Since the submitted paper departs significantly from the original idea, it would help to explain why the menu-level, RDD-based analysis was not pursued (e.g., data limitations, infeasible identification). Alternatively, recast the contribution to emphasize that the focus is on enterprise counts rather than menus but explain how this still addresses the core question of threshold-induced distortions. Doing so would aid readers in reconciling the paper’s scope with its stated policy motivation and the broader literature.

By implementing these suggestions, the paper can strengthen its causal claims, clarify its scope, and more convincingly speak to the policy question of whether size-based information mandates distort firm structures.
